Mast Cell Activation Syndrome (MCAS) Overview
Learn About Mast Cell Activation Syndrome (MCAS)
Do you suffer from a baffling and frustrating collection of seemingly unrelated symptoms? Perhaps you experience recurring skin rashes and hives, sudden episodes of abdominal cramping and diarrhea, a racing heart, and overwhelming “brain fog” all at the same time. For years, people with this type of multi-system illness have often been dismissed by the medical community, told their symptoms are “all in their head” or are simply due to anxiety. Today, however, there is growing recognition for a complex immune disorder that can explain this bewildering array of symptoms: Mast Cell Activation Syndrome (MCAS). MCAS is a condition where the body’s mast cells, a key part of the immune system, become overactive and release a flood of powerful chemical mediators for little or no reason. It is a real, physiological condition, and receiving a correct diagnosis can be a profoundly validating first step on the path to managing the symptoms and reclaiming your life.
To understand MCAS, it is essential to first understand the role of the mast cell. Mast cells are a type of white blood cell and are critical “first responders” of the immune system. They are found in all the body’s tissues that interface with the outside world, such as the skin, the lining of the gut, and the respiratory tract. Each mast cell is like a tiny grenade, packed with hundreds of small sacs (granules) that are filled with potent chemical weapons, including:
- Histamine (the well-known chemical involved in allergic reactions)
- Tryptase
- Prostaglandins
- Leukotrienes
In a healthy person, mast cells are stable and well-behaved. They only “degranulate” (release their chemical contents) when they detect a major threat, such as an allergen they are sensitized to (like pollen), a parasite, or tissue injury. This release of chemicals is what triggers the classic allergic response of swelling, redness, and itching, which is designed to protect the body.
In Mast Cell Activation Syndrome, the mast cells are hyper-responsive or “twitchy.” They have a faulty activation trigger.
- A helpful analogy is to think of the mast cells in your body as a network of highly sensitive, motion-activated security sprinklers installed in every room of your house. They are filled with a potent, messy mixture of inflammatory chemicals.
- In a normal house, these sprinklers only go off when there is a real, major fire.
- In MCAS, the sprinklers are defective and hypersensitive. Now, something as minor as a person walking by too quickly, a change in temperature, an emotional feeling, or sometimes nothing at all can trigger the sprinklers in the kitchen (causing GI symptoms), the living room (causing skin rashes), and the bedroom (causing palpitations) all at once.
- This inappropriate and widespread release of chemical mediators throughout the body is what causes the chronic, multi-system, and often bizarre symptoms of MCAS.
In my experience, patients with MCAS often struggle with years of vague, multisystem symptoms like flushing, GI distress, and fatigue before receiving a proper diagnosis.
The exact underlying cause of why a person’s mast cells become hyper-reactive is not yet fully understood. It is considered a primary immune disorder, and in some individuals, it may be related to underlying genetic mutations that make the mast cells inherently unstable.
It is crucial to distinguish MCAS from another, much rarer mast cell disorder called mastocytosis.
- In mastocytosis, the problem is having too many mast cells. It is a proliferative disorder, sometimes a form of cancer, where the body produces an abnormally high number of mast cells.
- In MCAS, the person has a normal number of mast cells. The problem is not the quantity of cells, but their quality and function. The cells are simply behaving badly and are too quick to release their chemical contents.
Clinically, I’ve seen that MCAS isn’t caused by one clear trigger, it’s thought to involve genetic predisposition, immune dysregulation, and over-reactivity of mast cells to otherwise harmless stimuli.
A person develops MCAS due to an underlying dysfunction of their mast cells. It is not contagious. While the underlying predisposition may be genetic, the symptoms themselves are often set off by a wide variety of triggers. A key part of living with MCAS is identifying and avoiding personal triggers.
The list of potential triggers is vast and can be unique to each individual. Common triggers include:
- Foods and Drinks: High-histamine foods (like aged cheeses, fermented foods, and processed meats), alcohol, and foods with preservatives or artificial dyes.
- Physical Stimuli: Heat, cold, sudden temperature changes, sunlight, friction or pressure on the skin, vibration, and exercise.
- Stress: Both physical stress (like an illness, injury, or surgery) and emotional stress are major triggers for mast cell degranulation.
- Environmental Factors: Strong odors (perfumes, cleaning products), mold, allergens like pollen or dust mites.
- Medications: A wide range of medications can trigger mast cells, including opioids, NSAIDs (like ibuprofen), some antibiotics, and anesthetic agents.
- Insect Bites or Stings.
In my experience, many cases seem to arise gradually without a clear starting point, patients often report that symptoms worsened after an illness or major stressor.
The symptoms of MCAS are notoriously diverse, can affect nearly every organ system in the body, and often occur in episodic “spells” or “attacks.” This is what makes the condition such a “great imitator” of other diseases. A person may experience a different combination of symptoms from one day to the next.
The most common signs and symptoms, grouped by body system, include:
- Skin (Most Common):
- Face, neck and chest flushing.
- Itching (pruritus).
- Hives (urticaria).
- Swelling (angioedema), especially of the face or lips.
- Cardiovascular:
- Rapid heart rate (tachycardia) or heart palpitations.
- A sudden drop in blood pressure (hypotension), leading to dizziness, lightheadedness, or fainting (syncope).
- Gastrointestinal:
- Abdominal cramping and pain.
- Nausea and vomiting.
- Chronic diarrhea.
- Respiratory:
- Wheezing or shortness of breath, similar to an asthma attack.
- Nasal congestion and throat swelling.
- Neurological / Constitutional:
- Headaches.
- “Brain fog,” difficulty with concentration and memory.
- A general feeling of anxiety or a “sense of impending doom.”
- Overwhelming fatigue.
Patients describe a mix of symptoms: skin flushing, itching, brain fog, abdominal cramping, diarrhea, and even lightheadedness often mistaken for anxiety or IBS.
Anaphylaxis
In its most severe form, the massive, body-wide release of mast cell mediators can cause anaphylaxis. This is a life-threatening allergic reaction where the blood pressure plummets and the airway swells shut, requiring an immediate injection of epinephrine.
Diagnosing MCAS can be a very long and challenging journey. It requires a knowledgeable specialist, usually an allergist or immunologist, who can piece together the complex puzzle. Diagnosis is based on a set of three specific criteria.
- Characteristic Symptoms: The patient must have typical, recurrent, and episodic symptoms of mast cell activation (like flushing, hives, cramping, and palpitations) that affect at least two or more organ systems.
- Evidence of Mast Cell Mediators: This is a crucial but often difficult step. A blood or urine test, which must be collected during or immediately after a symptomatic flare, must show a significant, transient rise in a specific mast cell mediator.
- The most common test is a serum tryptase level. Tryptase is an enzyme that is only released by mast cells, so a rise in its level after a spell is strong evidence of mast cell activation.
- Other tests can find high histamine or prostaglandin levels in a 24-hour urine collection.
- Response to Treatment: The patient’s symptoms must show a clear and significant improvement with the use of medications that block the effects of mast cell mediators (like antihistamines) or that stabilize mast cells.
The diagnostic workup also involves ruling out other conditions that can cause similar symptoms, such as mastocytosis, carcinoid syndrome, or pheochromocytoma.
Clinically, I rely on elevated mast cell mediators like tryptase, histamine, or prostaglandin along with symptom patterns and response to treatment to make a diagnosis.
There is no cure for MCAS. Management is a lifelong, personalized, and stepwise process aimed at avoiding triggers, stabilizing the mast cells, and blocking the effects of the chemicals they release.
1. Trigger Avoidance
This is the foundation of management. Keeping a detailed food and symptom diary is essential for helping a patient identify their personal triggers so they can be avoided.
2. A Stepwise Medication Plan
The medical treatment for MCAS follows a logical, step-up approach.
- Step 1: Histamine Blockers (The Cornerstone): The first and most important step is to block the effects of histamine, the primary mediator. This involves taking:
- H1 Antihistamines: These are standard allergy medications, such as cetirizine, loratadine, or fexofenadine.
- H2 Antihistamines: These are typically used for stomach acid (like famotidine), but they also block H2 histamine receptors elsewhere in the body.
- Patients with MCAS often take both H1 and H2 blockers daily.
- Step 2: Mast Cell Stabilizers: If antihistamines are not enough, the next step is to add medications that help to make the mast cells less “twitchy” and less likely to degranulate.
- Oral Cromolyn Sodium: This is a prescription medication that is particularly helpful for gastrointestinal symptoms.
- Ketotifen: An effective mast cell stabilizer that also has antihistamine properties.
- Step 3: Leukotriene Inhibitors: Medications like montelukast, which block another inflammatory mediator called leukotrienes, can be helpful, especially for respiratory symptoms.
3. Emergency Treatment for Severe Attacks
Every patient with MCAS who is at risk for severe episodes or anaphylaxis must have at least two epinephrine auto-injectors available at all times and be trained on how to use them.
4. Advanced Therapies
For patients with severe MCAS that does not respond to the standard treatments, a specialist may consider the use of omalizumab (Xolair®). This is a biologic medication, given by injection, that can help to stabilize mast cells and has been shown to be effective in some patients with refractory MCAS.
I’ve seen good results using H1 and H2 antihistamines, mast cell stabilizers like cromolyn, and lifestyle adjustments to avoid known triggers.
Mast Cell Activation Syndrome is a complex and often debilitating immune disorder that can make everyday life feel unpredictable and overwhelming. Its ability to cause a vast array of symptoms across every organ system makes it a true “great imitator,” leading to long and frustrating diagnostic journeys for many. However, a correct diagnosis of MCAS can be a life-changing moment of validation. It provides a single, unified explanation for a lifetime of mysterious symptoms. While there is no cure, a proactive and stepwise approach to management, starting with trigger avoidance and antihistamines and building from there can help to stabilize the hyper-reactive mast cells. This allows many individuals with MCAS to control their symptoms, reduce the frequency and severity of attacks, and regain a significant measure of control over their health and their lives.
- The Mast Cell Disease Society, Inc. (n.d.). Mast Cell Activation Syndrome (MCAS). Retrieved from https://tmsforacure.org/symptoms/mast-cell-activation-syndrome/
- American Academy of Allergy, Asthma & Immunology (AAAAI). (n.d.). Mast Cell Activation Syndrome. Retrieved from https://www.aaaai.org/conditions-and-treatments/related-conditions/mcas
- National Organization for Rare Disorders (NORD). (2024). Mast Cell Activation Syndrome. Retrieved from https://rarediseases.org/rare-diseases/mast-cell-activation-syndrome/
Dana-Farber Cancer Institute, Inc.
Daniel Deangelo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Deangelo is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Deangelo is currently accepting new patients.
Melody Carter is an Allergy and Immunologist and a Pediatrics provider in Bethesda, Maryland. Dr. Carter is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Urticaria Pigmentosa, Systemic Mastocytosis, and Anaphylaxis.
Stanford Medicine Cancer Center
Jason Gotlib is a Hematologist in Palo Alto, California. Dr. Gotlib is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Gotlib is currently accepting new patients.
Summary: This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cell...
Summary: This study will examine growth factors that promote and inhibit mast cell proliferation resulting in mastocytosis, a disease of excessive mast cells in the body. These cells can release chemicals that cause itching, blisters, flushing, bone pain and abdominal pain. Patients up to 80 years of age with mastocytosis may be eligible for this 1-day study. Participants will have one visit at NIH lasting...

